BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 12014638)

  • 1. Acyclo-retinoic acid induces apoptosis in human prostate cancer cells.
    Kotake-Nara E; Kim SJ; Kobori M; Miyashita K; Nagao A
    Anticancer Res; 2002; 22(2A):689-95. PubMed ID: 12014638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of acyclo-retinoic acid and lycopene on activation of the retinoic acid receptor and proliferation of mammary cancer cells.
    Ben-Dor A; Nahum A; Danilenko M; Giat Y; Stahl W; Martin HD; Emmerich T; Noy N; Levy J; Sharoni Y
    Arch Biochem Biophys; 2001 Jul; 391(2):295-302. PubMed ID: 11437362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of effective retinoids for inhibiting growth and inducing apoptosis in bladder cancer cells.
    Zou C; Liebert M; Zou C; Grossman HB; Lotan R
    J Urol; 2001 Mar; 165(3):986-92. PubMed ID: 11176527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nitroxide tempo, a small molecule, induces apoptosis in prostate carcinoma cells and suppresses tumor growth in athymic mice.
    Suy S; Mitchell JB; Samuni A; Mueller S; Kasid U
    Cancer; 2005 Mar; 103(6):1302-13. PubMed ID: 15685617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel therapeutic approach: organic arsenical melarsoprol) alone or with all-trans-retinoic acid markedly inhibit growth of human breast and prostate cancer cells in vitro and in vivo.
    Koshiuka K; Elstner E; Williamson E; Said JW; Tada Y; Koeffler HP
    Br J Cancer; 2000 Jan; 82(2):452-8. PubMed ID: 10646904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antagonists of retinoic acid receptors (RARs) are potent growth inhibitors of prostate carcinoma cells.
    Hammond LA; Van Krinks CH; Durham J; Tomkins SE; Burnett RD; Jones EL; Chandraratna RA; Brown G
    Br J Cancer; 2001 Aug; 85(3):453-62. PubMed ID: 11487280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential induction of apoptosis by all-trans-retinoic acid and N-(4-hydroxyphenyl)retinamide in human head and neck squamous cell carcinoma cell lines.
    Oridate N; Lotan D; Xu XC; Hong WK; Lotan R
    Clin Cancer Res; 1996 May; 2(5):855-63. PubMed ID: 9816241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ET-1 expression and growth inhibition of prostate cancer cells: a retinoid target with novel specificity.
    Hsu JY; Pfahl M
    Cancer Res; 1998 Nov; 58(21):4817-22. PubMed ID: 9809984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ceramide analog, B13, induces apoptosis in prostate cancer cell lines and inhibits tumor growth in prostate cancer xenografts.
    Samsel L; Zaidel G; Drumgoole HM; Jelovac D; Drachenberg C; Rhee JG; Brodie AM; Bielawska A; Smyth MJ
    Prostate; 2004 Mar; 58(4):382-93. PubMed ID: 14968439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stable expression of full length human androgen receptor in PC-3 prostate cancer cells enhances sensitivity to retinoic acid but not to 1alpha,25-dihydroxyvitamin D3.
    Murthy S; Marcelli M; Weigel NL
    Prostate; 2003 Sep; 56(4):293-304. PubMed ID: 12858358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The novel antimicrotubule agent cryptophycin 52 (LY355703) induces apoptosis via multiple pathways in human prostate cancer cells.
    Drew L; Fine RL; Do TN; Douglas GP; Petrylak DP
    Clin Cancer Res; 2002 Dec; 8(12):3922-32. PubMed ID: 12473608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of chelerythrine on cell growth, apoptosis, and cell cycle in human normal and cancer cells in comparison with sanguinarine.
    Malíková J; Zdarilová A; Hlobilková A; Ulrichová J
    Cell Biol Toxicol; 2006 Nov; 22(6):439-53. PubMed ID: 16964588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-vascular endothelial growth factor receptor 2 antibody reduces tumorigenicity and metastasis in orthotopic prostate cancer xenografts via induction of endothelial cell apoptosis and reduction of endothelial cell matrix metalloproteinase type 9 production.
    Sweeney P; Karashima T; Kim SJ; Kedar D; Mian B; Huang S; Baker C; Fan Z; Hicklin DJ; Pettaway CA; Dinney CP
    Clin Cancer Res; 2002 Aug; 8(8):2714-24. PubMed ID: 12171905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulation of gap junctional communication: comparison of acyclo-retinoic acid and lycopene.
    Stahl W; von Laar J; Martin HD; Emmerich T; Sies H
    Arch Biochem Biophys; 2000 Jan; 373(1):271-4. PubMed ID: 10620348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of retinoids on growth and metastasis of hamster melanoma in athymic mice.
    Schleicher RL; Moon RC; Patel MK; Beattie CW
    Cancer Res; 1988 Mar; 48(6):1465-9. PubMed ID: 3345519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The synthetic heteroarotinoid SHetA2 induces apoptosis in squamous carcinoma cells through a receptor-independent and mitochondria-dependent pathway.
    Chun KH; Benbrook DM; Berlin KD; Hong WK; Lotan R
    Cancer Res; 2003 Jul; 63(13):3826-32. PubMed ID: 12839980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allyl isothiocyanate, a constituent of cruciferous vegetables, inhibits growth of PC-3 human prostate cancer xenografts in vivo.
    Srivastava SK; Xiao D; Lew KL; Hershberger P; Kokkinakis DM; Johnson CS; Trump DL; Singh SV
    Carcinogenesis; 2003 Oct; 24(10):1665-70. PubMed ID: 12896904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Superior effectiveness of ibuprofen compared with other NSAIDs for reducing the survival of human prostate cancer cells.
    Andrews J; Djakiew D; Krygier S; Andrews P
    Cancer Chemother Pharmacol; 2002 Oct; 50(4):277-84. PubMed ID: 12357301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual effects of glutathione-S-transferase pi on As2O3 action in prostate cancer cells: enhancement of growth inhibition and inhibition of apoptosis.
    Lu M; Xia L; Luo D; Waxman S; Jing Y
    Oncogene; 2004 May; 23(22):3945-52. PubMed ID: 15007384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytostatic and apoptotic effects of bisphosphonates on prostate cancer cells.
    Dumon JC; Journé F; Kheddoumi N; Lagneaux L; Body JJ
    Eur Urol; 2004 Apr; 45(4):521-8; discussion 528-9. PubMed ID: 15041119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.